Exagen Retained Earnings 2011-2026 | XGN

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.

Possible uses include

reinvestment in development (R&D, equipment, marketing)
debt repayment
acquisition of other companies
creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Exagen

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-279 M	-256 M	-208 M	-181 M	-165 M	-153 M	-148 M	-	-108 M	-89.3 M	-74.3 M	-60.8 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-60.8 M	-279 M	-157 M

Quarterly Retained Earnings Exagen

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-310 M	-303 M	-298 M	-294 M	-291 M	-286 M	-283 M	-279 M	-274 M	-268 M	-263 M	-256 M	-241 M	-233 M	-218 M	-208 M	-201 M	-194 M	-187 M	-181 M	-181 M	-181 M	-181 M	-165 M	-165 M	-165 M	-165 M	-153 M	-153 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-153 M	-310 M	-227 M

Retained Earnings of other stocks in the Diagnostics research industry

Issuer	Retained Earnings	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-62.9 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	-280 M	-	-17.87 %	$ 25.9 M	Canada
BioNano Genomics BNGO	-693 M	$ 1.12	-0.88 %	$ 1.42 M	USA
Brainsway Ltd. BWAY	-77.3 M	$ 24.41	1.2 %	$ 99.4 M	Israel
Burning Rock Biotech Limited BNR	-2.23 B	$ 27.63	-4.06 %	$ 297 M	China
Aspira Women's Health AWH	-499 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-607 M	-	-61.36 %	$ 2.46 M	USA
Celcuity CELC	-272 M	$ 105.79	0.61 %	$ 4.17 B	USA
Danaher Corporation DHR	46.9 B	$ 209.19	-0.82 %	$ 149 B	USA
Biocept BIOC	-298 M	-	-13.05 %	$ 7.29 M	USA
DarioHealth Corp. DRIO	-349 M	$ 11.26	-	$ 319 M	Israel
Oxford Immunotec Global PLC OXFD	-84 M	-	-	$ 562 M	Britain
Check-Cap Ltd. CHEK	-170 M	-	-	$ 9.42 M	Israel
Fulgent Genetics FLGT	590 M	$ 23.09	0.35 %	$ 698 M	USA
Chembio Diagnostics CEMI	-154 M	-	0.22 %	$ 16.8 M	USA
Enzo Biochem ENZ	-294 M	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	4.6 M	-	-	$ 79.8 M	USA
Global Cord Blood Corporation CO	2.89 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-624 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-150 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-4.94 B	-	0.12 %	$ 80.1 M	China
Quest Diagnostics Incorporated DGX	9.36 B	$ 209.54	1.02 %	$ 23.3 B	USA
Castle Biosciences CSTL	-200 M	$ 29.94	3.46 %	$ 832 M	USA
PRA Health Sciences, Inc. PRAH	440 M	-	-	$ 10.7 B	USA
CareDx, Inc CDNA	-678 M	$ 19.25	2.45 %	$ 1.03 B	USA
Laboratory Corporation of America Holdings LH	8.64 B	$ 287.13	0.64 %	$ 23.9 B	USA
DermTech DMTK	-424 M	-	-11.32 %	$ 2.94 M	USA
DexCom DXCM	2.43 B	$ 73.09	-0.23 %	$ 28.5 B	USA
Interpace Biosciences IDXG	-235 M	$ 1.74	-5.95 %	$ 7.63 M	USA
Myriad Genetics MYGN	-1.12 B	$ 4.43	1.14 %	$ 410 M	USA
Exact Sciences Corporation EXAS	-4.71 B	$ 103.45	0.06 %	$ 19.5 B	USA
Natera NTRA	-1.94 B	$ 209.53	0.09 %	$ 20.6 B	USA
Pacific Biosciences of California PACB	-1.84 B	$ 1.66	5.06 %	$ 421 M	USA
Guardant Health GH	-2.99 B	$ 95.4	1.04 %	$ 12 B	USA
QIAGEN N.V. QGEN	2.45 B	-	-	$ 10.6 B	Niderland
Charles River Laboratories International CRL	1.39 B	$ 166.06	1.55 %	$ 8.23 B	USA
Heska Corporation HSKA	-169 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-230 M	-	-20.0 %	$ 1.06 M	USA
ICON Public Limited Company ICLR	2.72 B	$ 104.09	-0.54 %	$ 8.59 B	Irlanda
ENDRA Life Sciences NDRA	-103 M	$ 3.86	2.93 %	$ 2.07 M	USA
IDEXX Laboratories IDXX	6.39 B	$ 649.23	4.19 %	$ 52.2 B	USA
Illumina ILMN	-1.24 B	$ 122.9	1.96 %	$ 19.5 B	USA
IQVIA Holdings IQV	7.42 B	$ 164.88	1.58 %	$ 28.3 B	USA
Motus GI Holdings MOTS	-154 M	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	9.24 B	$ 1 379.66	-0.97 %	$ 28.4 B	Schweiz
Trinity Biotech plc TRIB	10.6 M	$ 0.75	6.99 %	$ 61.9 M	Irlanda
Biodesix BDSX	-462 M	$ 13.02	1.96 %	$ 1.69 B	USA
Quidel Corporation QDEL	945 M	$ 21.93	3.49 %	$ 924 M	USA
Twist Bioscience Corporation TWST	-1.32 B	$ 48.54	0.94 %	$ 2.9 B	USA